BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524322

KABRADG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KABRA DRUGS LTD. Share Price Update

As of the latest trading session, KABRA DRUGS LTD. share price is currently at ₹ 11.08, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 11.08 and ₹ 11.08. Over the past year, KABRA DRUGS LTD. has achieved a return of 54.10 %. In the last month alone, the return has been 0.00 %. Read More...

KABRA DRUGS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    26.30

  • P/E Ratio (TTM)

    -14.21

  • Beta

    -0.09

  • Book Value / share

    10.58

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.54

info icon alternate text

KABRA DRUGS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.54
Net Profit -0.54
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.53
EBITDA -0.54
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.40
Net Profit -0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.39
EBITDA -0.40
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.55
Net Profit -0.55
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.24
EBITDA -0.55
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit -0.37
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.84
EBITDA -0.37
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit -0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.25
EBITDA -0.11
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.74
Net Profit -0.74
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.68
EBITDA -0.74
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.34
Net Profit -0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.77
EBITDA -0.34
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit -0.19
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.42
EBITDA -0.18
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.18
Net Profit -0.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.41
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.14
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 8.83
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -0.90
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -0.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -0.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.67
Total Assets 4.57
Total Liabilities 4.57
Total Equity 1.08
Share Outstanding 4388600
Price to Book Ratio -2.15
Return on Assets (%) -16.10
Return on Capital (%) -26.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.70
Total Liabilities 0.70
Total Equity -0.73
Share Outstanding 4388600
Price to Book Ratio -3.34
Return on Assets (%) -48.02
Return on Capital (%) -51.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.72
Total Liabilities 0.72
Total Equity -0.39
Share Outstanding 4388600
Price to Book Ratio -5.06
Return on Assets (%) -25.40
Return on Capital (%) -29.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.40
Total Liabilities 1.40
Total Equity -0.20
Share Outstanding 4388600
Price to Book Ratio 0.00
Return on Assets (%) -12.83
Return on Capital (%) -25.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 1.41
Total Liabilities 1.41
Total Equity -0.02
Share Outstanding 4388600
Price to Book Ratio -52.33
Return on Assets (%) -4.21
Return on Capital (%) -9.54
Particulars MAR 2024 (Values in Cr)
Net Income -0.73
Cash from Operations -0.20
Cash from Investing 0.00
Cash from Financing 2.87
Net change in Cash 2.66
Free Cash Flow -0.20
Particulars MAR 2023 (Values in Cr)
Net Income -0.33
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 0.35
Net change in Cash 0.00
Free Cash Flow -0.35
Particulars MAR 2022 (Values in Cr)
Net Income -0.18
Cash from Operations -0.13
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.13
Particulars MAR 2021 (Values in Cr)
Net Income -0.18
Cash from Operations -0.24
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.00
Free Cash Flow -0.24
Particulars MAR 2020 (Values in Cr)
Net Income -0.05
Cash from Operations -0.04
Cash from Investing 0.06
Cash from Financing -0.01
Net change in Cash 0.00
Free Cash Flow -0.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

KABRA DRUGS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
11.08 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 11.00
  • 26 Days 10.20
  • 10 Days 10.90
  • 50 Days 9.30
  • 12 Days 10.80
  • 100 Days 7.90
  • 20 Days 10.40
  • 200 Days 6.50
11.08 PIVOT

First Support

11.08

First Resistance

11.08

Second Support

11.08

Second Resistance

11.08

Third Support

11.08

Third Resistance

11.08

RSI

0.00

ADX

100.00

MACD

0.57

Williams % R

0.00

Commodity Channel Index (CCI)

96.45

Date

2025-04-28

Week

4501.00

Same Day

201.00

Month

2027.00

1 Year

-0.09

3 Year

-0.28

Over 1 Month

0.00%

down

Over 1 Year

54.10%

down

Over 3 Months

10.13%

down

Over 3 Years

51.12%

down

Over 6 Months

21.22%

down

Over 5 Years

23.60%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

KABRA DRUGS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
100.0%
Promoter Holdings
0.0%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Vijay Kumar Reddy Veeramreddy 800000.0 (3.37%) Public Shareholding
Kuniamuthur Nanjappan Anand 658500.0 (2.78%) Public Shareholding
Priyam Samir Shah 650000.0 (2.74%) Public Shareholding
Himanshu Rajendra Kumar Jain . 500000.0 (2.11%) Public Shareholding
Kruti Sevanti Doshi 500000.0 (2.11%) Public Shareholding
Chandraprakash Jamnalal Kabra 400000.0 (1.69%) Public Shareholding
Farahan Karim Amalani 350000.0 (1.48%) Public Shareholding
Muralidharan.r 307000.0 (1.29%) Public Shareholding
Somisetty Malathi Latha 300000.0 (1.27%) Public Shareholding
Neha Sagar Shah 250000.0 (1.05%) Public Shareholding
Sagar Praful Shah 250000.0 (1.05%) Public Shareholding

News

Left Arrow
Right Arrow

KABRA DRUGS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KABRA DRUGS LTD. Share Price

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.

The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence.

With manufacturing and regular supply in the domestic market for injectables, soft gelatin capsules and liquids (oral and external especially alcohol products) the company now looks at the global market. A number of new products have been developed for the same.

Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. These are WHO-GMP, cGMP & Schedule 'M' approved facilities which also helps to get business approvals for Government, Semi- Government under takings , big institutions and other N.G.O's. Besides, they are also actively involved in trading and marketing of biological API's and Biochemicals.

Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have already been undertaken by the Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Kabra Drugs Ltd?

Answer Field

The share price of Kabra Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 11.08.

What is the Market Cap of Kabra Drugs Ltd?

Answer Field

The market cap of Kabra Drugs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 26.30 Cr. as of now.

What is the 52 Week High and Low of Kabra Drugs Ltd?

Answer Field

The 52 Week High and Low of Kabra Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 11.08 and ₹ 7.19.

How to Buy Kabra Drugs Ltd share?

Answer Field

You can trade in Kabra Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kabra Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 54.10%.

What is the Current Share Price of Kabra Drugs Ltd?

Answer Field

Kabra Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 11.08 as on Apr 28 2025 12:00 AM.

What is the Market Cap of Kabra Drugs Ltd Share?

Answer Field

The market cap of Kabra Drugs Ltd for NSE ₹ 0.0 & for BSE ₹ 26.30 as on Apr 28 2025 12:00 AM.

What is the P/E Ratio of Kabra Drugs Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM the price-to-earnings (PE) ratio for Kabra Drugs Ltd share is -14.21.

What is the PB ratio of Kabra Drugs Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM, the price-to-book (PB) ratio for Kabra Drugs Ltd share is 10.58.

How to Buy Kabra Drugs Ltd Share?

Answer Field

You can trade in Kabra Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kabra Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Kabra Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kabra Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|